Acute changes in dietary ω-3 and ω-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1

Journal of Immunology

Volumn 182, Issue 5, 2009, Pages 3223-3232

  Hassan, Iram R ^a   Gronert, Karsten ^a,b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; CHEMOKINE; CREATININE; CYTOKINE; DOCOSAHEXAENOIC ACID; HEME OXYGENASE 1; ICOSANOID; LIPOXYGENASE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROSTAGLANDIN SYNTHASE; 17 HYDROXY 4,7,10,13,15,19 DOCOSAHEXAENOIC ACID; 17-HYDROXY-4,7,10,13,15,19-DOCOSAHEXAENOIC ACID; NEUROPROTECTIN D1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; KIDNEY INJURY; KIDNEY ISCHEMIA; LIPIDOMICS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RENAL PROTECTION; SURVIVAL RATE; ACUTE KIDNEY FAILURE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; DIET THERAPY; DOWN REGULATION; GENETICS; MALE; METABOLISM; MORTALITY; PHYSIOLOGY; UPREGULATION;

ANIMALS; DOCOSAHEXAENOIC ACIDS; DOWN-REGULATION; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HEME OXYGENASE-1; KIDNEY FAILURE, ACUTE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; UP-REGULATION;

EID: 64849091646     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802064     Document Type: Article

References (68)

1. Bonventre, J. V., and A. Zuk. 2004. Ischemic acute renal failure: an inflammatory disease? Kidney. Int. 66: 480-485.
2. Kumar, V., N. Fausto, and A. Abbas. 2004. Robbins and Cotran Pathological Basis of Disease. Saunders, Philadelphia.
3. Singbartl, K., and K. Ley. 2004. Leukocyte recruitment and acute renal failure. J. Mol. Med. 82: 91-101.
4. Kremer, J. M. 2000. n-3 fatty acid supplements in rheumatoid arthritis. Am. J. Clin. Nutr. 71: 349S-351S.
5. Blok, W. L., M. B. Katan, and J. W. van der Meer. 1996. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J. Nutr. 126: 1515-1533.
6. Simopoulos, A. P. 2002. Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr. 21: 495-505.
7. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico-Prevenzione Investigators. 1999. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354: 447-455.
8. Donadio, J. V., and J. P. Grande. 2002. IgA nephropathy. N. Engl. J. Med. 347: 738-748.
9. Arterburn, L. M., E. B. Hall, and H. Oken. 2006. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 83(Suppl.): 1467S-1476S.
10. Tomobe, Y. I., K. Morizawa, M. Tsuchida, H. Hibino, Y. Nakano, and Y. Tanaka. 2000. Dietary docosahexaenoic acid suppresses inflammation and immunoresponses in contact hypersensitivity reaction in mice. Lipids 35: 61-69.
11. De Caterina, R., J. K. Liao, and P. Libby. 2000. Fatty acid modulation of endothelial activation. Am. J. of Clin. Nutr. 71(Suppl.): 213S-223S.
12. Kielar, M. L., D. R. Jeyarajah, X. J. Zhou, and C. Y. Lu. 2003. Docosahexaenoic acid ameliorates murine ischemic acute renal failure and prevents increases in mRNA abundance for both TNF-α and inducible nitric oxide synthase. J. Am. Soc. Nephrol. 14: 389-396.
13. Neumayer, H. H., M. Heinrich, M. Schmissas, H. Haller, K. Wagner, and F. C. Luft. 1992. Amelioration of ischemic acute renal failure by dietary fish administration in conscious dogs. J. Am. Soc. Nephrol. 3: 1312-1320.
14. Serhan, C. N. 2007. Resolution phase of inflammation: novel endogenous antiinflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25: 101-137.
15. Serhan, C. N., N. Chiang, and T. E. Van Dyke. 2008. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 349-361.
16. Gronert, K., and I. R. Hassan. 2007. Reaping the benefits of renal protective lipid autacoids. Drug Discov. Today Dis. Mech. 4: 3-10.
17. Bazan, N. G. 2006. Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci. 29: 263-271.
18. Serhan, C. N., K. Gotlinger, S. Hong, Y. Lu, J. Siegelman, T. Baer, R. Yang, S. P. Colgan, and N. A. Petasis. 2006. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 176: 1848-1859.
19. Duffield, J. S., S. Hong, V. S. Vaidya, Y. Lu, G. Fredman, C. N. Serhan, and J. V. Bonventre. 2006. Resolvin D series and protectin D1 mitigate acute kidney injury. J. Immunol. 177: 5902-5911.
20. Hassan IR, G. K. 2006. 15-Lipoxygenase and docosahexaenoic acid derived lipid mediators ameliorate inflammation and augment heme oxygenase-1 expression acute renal failure. Prostaglandins Other Lipid Mediat. 79: 141-194.
21. 4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing. FASEB J. 21: 2257-2266.
22. Abraham, N. G., and A. Kappas. 2008. Pharmacological and clinical aspects heme oxygenase. Pharmacol. Rev. 60: 79-127.
23. Ryter, S. W., J. Alam, and A. M. Choi. 2006. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86: 583-650.
24. Akagi, R., T. Takahashi, and S. Sassa. 2005. Cytoprotective effects of heme oxygenase in acute renal failure. Contrib. Nephrol. 148: 70-85.
25. Toda, N., T. Takahashi, S. Mizobuchi, H. Fujii, K. Nakahira, S. Takahashi, M. Yamashita, K. Morita, M. Hirakawa, and R. Akagi. 2002. Tin chloride pre-treatment prevents renal injury in rats with ischemic acute renal failure. Crit. Care Med. 30: 1512-1522.
26. Nath, K. A., J. J. Haggard, A. J. Croatt, J. P. Grande, K. D. Poss, and J. Alam. 2000. The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am. J. Pathol. 156: 1527-1535.
27. Datta, P. K., S. B. Koukouritaki, K. A. Hopp, and E. A. Lianos. 1999. Heme oxygenase-1 induction attenuates inducible nitric oxide synthase expression and proteinuria in glomerulonephritis. J. Am. Soc. Nephrol. 10: 2540-2550.
28. Agarwal, A., J. Balla, J. Alam, A. J. Croatt, and K. A. Nath. 1995. Induction heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat. Kidney Int. 48: 1298-1307.
29. Goncalves, G. M., M. A. Cenedeze, C. Q. Feitoza, P. M. Wang, A. P. Bertocchi, M. J. Damiao, H. S. Pinheiro, V. P. Antunes Teixeira, M. A. dos Reis, A. Pacheco-Silva, and N. O. Camara. 2006. The role of heme oxygenase 1 rapamycin-induced renal dysfunction after ischemia and reperfusion injury. Kidney Int. 70: 1742-1749.
30. Hong, S., K. Gronert, P. R. Devchand, R. L. Moussignac, and C. N. Serhan. 2003. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid murine brain, human blood, and glial cells: autacoids in anti-inflammation. J. Biol. Chem. 278: 14677-14687.
31. Gronert, K., N. Maheshwari, N. Khan, I. R. Hassan, M. Dunn, and M. Laniado Schwartzman. 2005. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J. Biol. Chem. 280: 15267-15278.
32. Meldrum, K. K., D. R. Meldrum, X. Meng, L. Ao, and A. H. Harken. 2002. TNF-α-dependent bilateral renal injury is induced by unilateral renal ischemia-reperfusion. Am. J. Physiol. Heart Circ. Physiol. 282: H540-546.
33. Lemay, S., H. Rabb, G. Postler, and A. K. Singh. 2000. Prominent and sustained up-regulation of gp130-signaling cytokines and the chemokine MIP-2 in murine renal ischemia-reperfusion injury. Transplantation 69: 959-963.
34. Ausiello, D. A., J. I. Kreisberg, C. Roy, and M. J. Karnovsky. 1980. Contraction of cultured rat glomerular cells of apparent mesangial origin after stimulation with angiotensin II and arginine vasopressin. J. Clin. Invest. 65: 754-760.
35. Gronert, K., C. B. Clish, M. Romano, and C. N. Serhan. 1999. Transcellular regulation of eicosanoid biosynthesis. Methods Mol. Biol. 120: 119-144.
36. Murphy, R. C., R. M. Barkley, K. Zemski Berry, J. Hankin, K. Harrison, C. Johnson, J. Krank, A. McAnoy, C. Uhlson, and S. Zarini. 2005. Electrospray ionization and tandem mass spectrometry of eicosanoids. Anal. Biochem. 346: 1-42.
37. Serhan, C. N., S. Hong, K. Gronert, S. P. Colgan, P. R. Devchand, G. Mirick, and R. L. Moussignac. 2002. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196: 1025-1037.
38. Takahashi, T., K. Morita, R. Akagi, and S. Sassa. 2004. Protective role of heme oxygenase-1 in renal ischemia. Antioxid. Redox Signal. 6: 867-877.
39. Maines, M. D., R. D. Mayer, J. F. Ewing, and W. K. McCoubrey, Jr. 1993. Induction of kidney heme oxygenase-1 (HSP32) mRNA and protein by ischemia/reperfusion: possible role of heme as both promotor of tissue damage and regulator of HSP32. J. Pharmacol. Exp. Ther. 264: 457-462.
40. Seta, F., L. Bellner, R. Rezzani, R. F. Regan, M. W. Dunn, N. G. Abraham, K. Gronert, and M. Laniado-Schwartzman. 2006. Heme oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response. Am. J. Pathol. 169: 1612-1623.
41. McMahon, B., S. Mitchell, H. R. Brady, and C. Godson. 2001. Lipoxins: revelations on resolution. Trends Pharmacol. Sci. 22: 391-395.
42. Goligorsky, M. S., and J. H. Stein, eds. 1995. Acute Renal Failure: New Concepts and Therapeutic Strategies. Saunders, Philadelphia.
43. James, M. J., R. A. Gibson, and L. G. Cleland. 2000. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr. 71(Suppl.): 343S-348S.
44. Kromann, N., and A. Green. 1980. Epidemiological studies in the Upernavik district, Greenland: incidence of some chronic diseases 1950-1974. Acta. Med. Scand. 208: 401-406.
45. Hibbeln, J. R., L. R. Nieminen, T. L. Blasbalg, J. A. Riggs, and W. E. Lands. 2006. Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am. J. Clin. Nutr. 83(Suppl.): 1483S-1493S.
46. De Caterina, R., S. Endres, S. D. Kristensen, and E. B. Schmidt, eds. 1993. n-3 Fatty Acids and Vascular Disease. Springer, London.
47. Mori, T. A. 2006. Omega-3 fatty acids and hypertension in humans. Clin. Exp. Pharmacol. Physiol. 33: 842-846.
48. Simopoulos, A. P., A. Leaf, and N. Salem, Jr. 1999. Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J. Am. Coll. Nutr. 18: 487-489.
49. Donadio, J. V., and J. P. Grande. 2004. The role of fish oil/omega-3 fatty acids in the treatment of IgA nephropathy. Semin. Nephrol. 24: 225-243.
50. Jia, Q., Y. Shi, M. B. Bennink, and J. J. Pestka. 2004. Docosahexaenoic acid and eicosapentaenoic acid, but not α-linolenic acid, suppress deoxynivalenol-induced experimental IgA nephropathy in mice. J. Nutr. 134: 1353-1361.
51. Levy, B. D., P. Kohli, K. Gotlinger, O. Haworth, S. Hong, S. Kazani, E. Israel, K. J. Haley, and C. N. Serhan. 2007. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J. Immunol. 178: 496-502.
52. Calviello, G., P. Palozza, F. Di Nicuolo, N. Maggiano, and G. M. Bartoli. 2000. n-3 PUFA dietary supplementation inhibits proliferation and store-operated calcium influx in thymoma cells growing in Balb/c mice. J. Lipid. Res. 41: 182-189.
53. Chavali, S. R., C. E. Weeks, W. W. Zhong, and R. A. Forse. 1998. Increased production of TNF-α and decreased levels of dienoic eicosanoids, IL-6 and IL-10 in mice fed menhaden oil and juniper oil diets in response to an intraperitoneal lethal dose of LPS. Prostaglandins Leukot. Essent. Fatty Acids 59: 89-93.
54. Higuchi, T., N. Shirai, and H. Suzuki. 2006. Reduction in plasma glucose after lipid changes in mice fed fish oil, docosahexaenoic acid, and eicosapentaenoic acid diets. Ann. Nutr. Metab. 50: 147-154.
55. Leslie, C. A., W. A. Gonnerman, M. D. Ullman, K. C. Hayes, C. Franzblau, and E. S. Cathcart. 1985. Dietary fish oil modulates macrophage fatty acids and decreases arthritis susceptibility in mice. J. Exp. Med. 162: 1336-1349.
56. Mustad, V. A., S. Demichele, Y. S. Huang, A. Mika, N. Lubbers, N. Berthiaume, J. Polakowski, and B. Zinker. 2006. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse. Metabolism 55: 1365-1374.
57. Riediger, N. D., R. Othman, E. Fitz, G. N. Pierce, M. Suh, and M. H. Moghadasian. 2008. Low n-6:n-3 fatty acid ratio, with fish- or flaxseed oil, in a high fat diet improves plasma lipids and beneficially alters tissue fatty acid composition in mice. Eur. J. Nutr. 47: 153-160.
58. Triggiani, M., T. R. Connell, and F. H. Chilton. 1990. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor. J. Immunol. 145: 2241-2248.
59. Whelan, J., B. Li, and C. Birdwell. 1997. Dietary arachidonic acid increases eicosanoid production in the presence of equal amounts of dietary eicosapentaenoic acid. Adv. Exp. Med. Biol. 400B: 897-904.
60. Munger, K. A., A. Montero, M. Fukunaga, S. Uda, T. Yura, E. Imai, Y. Kaneda, J. M. Valdivielso, and K. F. Badr. 1999. Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis. Proc. Natl. Acad. Sci. USA 96: 13375-13380.
61. 4 analogues with enhanced chemical and metabolic stability have anti-inflammatory activity in vivo. J. Med. Chem. 47: 2157-2165.
62. Sun, Y. P., S. F. Oh, J. Uddin, R. Yang, K. Gotlinger, E. Campbell, S. P. Colgan, N. A. Petasis, and C. N. Serhan. 2007. Resolvin D1 and its aspirin-triggered 17R epimer: stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J. Biol. Chem. 282: 9323-9334.
63. Schwab, J. M., N. Chiang, M. Arita, and C. N. Serhan. 2007. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447: 869-874.
64. 4, is protective in experimental ischemic acute renal failure. J. Am. Soc. Nephrol. 13: 1657-1662.
65. 4 induces heme oxygenase-1 in endothelial cells. Am. J. Physiol. 289: C557-C563.
66. Koizumi, T., N. Odani, T. Okuyama, A. Ichikawa, and M. Negishi. 1995. Identification of a cis-regulatory element for delta 12-prostaglandin J2-induced expression of the rat heme oxygenase gene. J. Biol. Chem. 270: 21779-21784.
67. Gaedeke, J., N. A. Noble, and W. A. Border. 2005. Curcumin blocks fibrosis in anti-Thy 1 glomerulonephritis through up-regulation of heme oxygenase 1. Kidney Int. 68: 2042-2049.
68. Zhang, X., L. Lu, C. Dixon, W. Wilmer, H. Song, X. Chen, and B. H. Rovin. 2004. Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-delta12, 14-prostaglandin J2 in human mesangial cells. Kidney Int. 65: 798 - 810.